Announced that it has extended its drug discovery and development collaboration with Allergan today.

Food and Drug Administration.. ACADIA extends collaboration agreement with Allergan for drug discovery platform ACADIA Pharmaceuticals Inc. , a biopharmaceutical business utilizing innovative technology to gasoline drug discovery and scientific development of novel remedies for central nervous program disorders, announced that it has extended its drug discovery and development collaboration with Allergan today, Inc. . The collaboration is focused on the discovery of innovative new therapeutics for glaucoma and other ophthalmic indications and was originally established in March 2003.Even worse, by creating a scholarly study in a particular way, you can take almost any chemical, including highly toxic chemicals, and tweak out some sort of positive claim through the use of enough people with enough studies and approaching it with a thoroughly chosen study design. For example, one of the tricks drug companies play with clinical trials is to remove people from the trial who aren’t showing the required positive results. A trial may begin out with 200 people, but after 3 months, if certain individuals aren’t showing the desired results, such as lower cholesterol or stabilized blood sugar levels, they could be dismissed from the trial for a number of reasons simply.